Please login to the form below

Not currently logged in
Email:
Password:

Rapivab

This page shows the latest Rapivab news and features for those working in and with pharma, biotech and healthcare.

BioCryst gets FDA nod for first intravenous flu drug

BioCryst gets FDA nod for first intravenous flu drug

The FDA gave the go-ahead yesterday for Rapivab (peramivir) to treat flu in adults who have been symptomatic for no more than two days, suggesting that regulatory compliance issues at ... Edward Cox, director of the Office of Antimicrobial Products at

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Pharma deals in June 2015 Pharma deals in June 2015

    85. BioCryst Pharmaceuticals/ CSL. RAPIVAB (peramivir injection) for the treatment of influenza (marketed).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics